Calamos Advisors LLC Has $46.59 Million Position in Teradyne, Inc. $TER

Calamos Advisors LLC reduced its position in Teradyne, Inc. (NASDAQ:TERFree Report) by 2.8% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 96,290 shares of the company’s stock after selling 2,814 shares during the period. Calamos Advisors LLC owned 0.06% of Teradyne worth $46,589,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp boosted its holdings in Teradyne by 0.9% in the fourth quarter. State Street Corp now owns 7,078,635 shares of the company’s stock valued at $1,370,141,000 after acquiring an additional 60,986 shares during the last quarter. Ameriprise Financial Inc. increased its position in Teradyne by 3.0% in the second quarter. Ameriprise Financial Inc. now owns 4,920,100 shares of the company’s stock worth $442,413,000 after purchasing an additional 143,058 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Teradyne by 18.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock worth $813,640,000 after purchasing an additional 659,273 shares during the last quarter. Invesco Ltd. lifted its position in Teradyne by 3.5% during the 3rd quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock valued at $407,322,000 after purchasing an additional 99,864 shares during the period. Finally, Morgan Stanley lifted its position in Teradyne by 1.9% during the 4th quarter. Morgan Stanley now owns 2,442,014 shares of the company’s stock valued at $472,677,000 after purchasing an additional 45,089 shares during the period. Institutional investors own 99.77% of the company’s stock.

Teradyne Stock Performance

Shares of TER stock opened at $418.79 on Friday. The company has a market capitalization of $65.47 billion, a P/E ratio of 57.45, a price-to-earnings-growth ratio of 0.83 and a beta of 1.78. The company’s 50 day moving average price is $384.26 and its two-hundred day moving average price is $348.39. Teradyne, Inc. has a 52 week low of $106.30 and a 52 week high of $487.91.

Teradyne (NASDAQ:TERGet Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $2.47 earnings per share for the quarter, beating the consensus estimate of $2.09 by $0.38. Teradyne had a net margin of 25.77% and a return on equity of 39.93%. The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter in the prior year, the company earned $0.57 earnings per share. The business’s quarterly revenue was up 103.9% compared to the same quarter last year. Analysts forecast that Teradyne, Inc. will post 9.1 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Gregory Stephen Smith sold 4,000 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $423.03, for a total transaction of $1,692,120.00. Following the completion of the transaction, the chief executive officer directly owned 120,470 shares of the company’s stock, valued at $50,962,424.10. This represents a 3.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shannon John Poulin sold 1,008 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $345.37, for a total value of $348,132.96. Following the transaction, the insider owned 15,066 shares of the company’s stock, valued at approximately $5,203,344.42. The trade was a 6.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 5,664 shares of company stock valued at $2,273,133. Company insiders own 0.19% of the company’s stock.

Analysts Set New Price Targets

TER has been the topic of a number of recent research reports. Robert W. Baird set a $420.00 price objective on shares of Teradyne in a research note on Thursday, July 30th. Zacks Research raised Teradyne from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 12th. Evercore restated an “outperform” rating and issued a $420.00 price target on shares of Teradyne in a research report on Thursday, July 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $550.00 price objective on shares of Teradyne in a research note on Wednesday, July 29th. Finally, Citigroup upped their price objective on Teradyne from $325.00 to $400.00 and gave the company a “buy” rating in a report on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $396.80.

Read Our Latest Stock Analysis on Teradyne

Teradyne Company Profile

(Free Report)

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.

See Also

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.